Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The provided claim aligns with the label’s stated indications and intent for immediate administration in at-risk patients.
Category Scores
Accurate Statements
EpiPen and EpiPen Jr are indicated for the emergency treatment of Type I allergic reactions including anaphylaxis, and are intended for immediate administration in patients at increased risk for anaphylaxis.
Supported by Section 1 INDICATIONS AND USAGE and reinforced by emergency supportive therapy intent in Section 5 WARNINGS AND PRECAUTIONS.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
No dosing, contraindications, warnings, or administration-limit claims were made beyond what is already reflected in the label-supported indication/intent statement.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement